MARK2 and breast carcinoma: Nevertheless, current results show that active FGFR4 tyrosine phosphorylates and inactivates the pro-apoptotic MST1/2 serine/threonine kinase in breast cancer cells, thus revealing a novel mechanism of RTK-mediated apoptosis evasion and oncogenic FGFR4 function.